Stuttgart - Delayed Quote EUR

Vivani Medical Inc (U5P.SG)

Compare
1.1500
0.0000
(0.00%)
At close: January 10 at 9:35:53 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
24,434.0000
26,965.0000
21,241.0000
13,323.0000
9,243.0000
Operating Income
-24,434.0000
-26,965.0000
-21,241.0000
-13,323.0000
-9,243.0000
Other Income Expense
972.0000
1,313.0000
7,352.0000
550.0000
-36.0000
Pretax Income
-23,462.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Net Income Common Stockholders
-23,462.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Diluted NI Available to Com Stockholders
-23,462.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Basic EPS
-0.43
-0.50
-0.36
-0.39
-0.28
Diluted EPS
-0.43
-0.50
-0.36
-0.39
-0.28
Basic Average Shares
53,406.0000
50,853.0000
38,241.0000
33,092.0000
33,092.0000
Diluted Average Shares
53,406.0000
50,853.0000
38,241.0000
33,092.0000
33,092.0000
Total Operating Income as Reported
-24,434.0000
-26,965.0000
-21,241.0000
-13,323.0000
-9,243.0000
Total Expenses
24,434.0000
26,965.0000
21,241.0000
13,323.0000
9,243.0000
Net Income from Continuing & Discontinued Operation
-23,462.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Normalized Income
-23,462.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
EBIT
-24,434.0000
-26,965.0000
-21,241.0000
-13,323.0000
-9,243.0000
EBITDA
-24,025.0000
-26,608.0000
-20,860.0000
-12,978.0000
-8,889.0000
Reconciled Depreciation
409.0000
357.0000
381.0000
345.0000
354.0000
Net Income from Continuing Operation Net Minority Interest
-23,462.0000
-25,652.0000
-13,889.0000
-12,773.0000
-9,279.0000
Total Unusual Items Excluding Goodwill
641.0000
--
6,877.0000
--
--
Total Unusual Items
641.0000
--
6,877.0000
--
--
Normalized EBITDA
-24,025.0000
-26,608.0000
-20,860.0000
-12,978.0000
-8,889.0000
12/31/2020 - 9/6/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UR9.SG Clinuvel Pharmaceuticals Ltd
6.87
+0.73%
 
LT4.F Liquidia Corporation
12.00
+0.42%
 
22UA.F BioNTech SE
120.20
+1.52%
 
IKT Inhibikase Therapeutics, Inc.
2.9500
-4.84%
 
QTTB Q32 Bio Inc.
3.3400
+2.14%
 
IVVD Invivyd, Inc.
0.4520
-2.06%
 
ATYR aTyr Pharma, Inc.
3.5300
-5.61%
 
VOR Vor Biopharma Inc.
1.5550
-4.60%
 
PALI Palisade Bio, Inc.
1.9100
-4.98%
 
NNVC NanoViricides, Inc.
1.3500
-2.88%